Payment Solutions

Search documents
CLASS ACTION REMINDER: Berger Montague Advises Fiserv, Inc. (NYSE: FI) Investors to Inquire About a Securities Fraud Lawsuit by September 22, 2025
Prnewswire· 2025-09-02 21:12
Core Viewpoint - Berger Montague PC is investigating claims against Fiserv, Inc. following a class action lawsuit alleging that the company overstated its growth by not disclosing issues with its Clover payment platform [1][3]. Group 1: Lawsuit Details - The class action lawsuit claims that Fiserv and certain executives failed to disclose that Clover's revenue growth was artificially inflated due to the forced transition of merchants from the legacy Payeezy platform [3]. - Investors became aware of Fiserv's true financial situation after the company lowered its 2025 organic growth projections on July 23, 2025, leading to a significant decline in share price [4]. Group 2: Investor Information - Investors who purchased Fiserv securities between July 24, 2024, and July 22, 2025, have until September 22, 2025, to seek appointment as lead plaintiff representatives [2][5].
Here's Why Corpay (CPAY) is a Strong Value Stock
ZACKS· 2025-08-27 14:41
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style Sc ...
CompoSecure Highlights its Arculus Onchain Tap-to-Pay Capability and Showcases Innovation at Stablecoin Conference LATAM 2025
GlobeNewswire News Room· 2025-08-26 20:01
Core Insights - CompoSecure, Inc. is showcasing its Arculus direct onchain tap-to-pay capability at the Stablecoin Conference LATAM 2025, highlighting advancements in integrating crypto payments with traditional commerce [1][5] Group 1: Arculus Solution Overview - The Arculus direct onchain tap-to-pay solution bridges the crypto economy with real-world commerce, facilitating seamless transactions at traditional point-of-sale (POS) terminals [2] - This solution allows multifunctional capabilities on a single chip, enabling tap-to-pay transactions across both blockchain networks and traditional payment systems [2] Group 2: Benefits for Stakeholders - For POS providers, Arculus offers direct integration with existing systems without requiring new hardware, allowing them to accept crypto payments alongside traditional card payments [3] - Merchants can accept crypto payments instantly through existing contactless infrastructure, reducing friction at checkout and attracting a growing base of crypto users [3] - Onchain payments can lower transaction costs and settlement times compared to legacy payment networks, providing additional value to merchants [3] Group 3: Consumer and Wallet Provider Advantages - Arculus's wallet integration enables wallet providers to offer a tap-to-pay experience, allowing consumers to spend digital assets easily while maintaining self-custody and security [4] Group 4: Conference Presentation - Tom D'Eletto, Head of Arculus Products, will discuss the importance of security and user experience in the adoption of digital assets at the Stablecoin Conference LATAM [5][8]
INVESTOR REMINDER: Berger Montague Notifies Fiserv, Inc. (NYSE: FI) Investors of a Class Action Lawsuit and Deadline
Prnewswire· 2025-08-11 21:19
Core Viewpoint - Berger Montague PC is investigating claims against Fiserv, Inc. following a class action lawsuit alleging that the company overstated its growth by not disclosing issues with its Clover payment platform [1][3]. Group 1: Lawsuit Details - The class action lawsuit claims that Fiserv and certain executives failed to disclose that Clover's revenue growth was artificially inflated due to the forced transition of merchants from the legacy Payeezy platform [3]. - Investors who acquired Fiserv securities between July 24, 2024, and July 22, 2025, can seek to be appointed as lead plaintiff representatives by the deadline of September 22, 2025 [2][5]. Group 2: Financial Impact - Fiserv's share price experienced a significant decline following disclosures on July 23, 2025, when the company lowered its 2025 organic growth projections and confirmed decelerated growth in its Merchant segment [4].
CLASS ACTION NOTICE: Berger Montague Advises Fiserv, Inc. (NYSE: FI) Investors to Inquire About a Securities Fraud Class Action
GlobeNewswire News Room· 2025-08-04 19:11
Core Viewpoint - Berger Montague PC is investigating claims against Fiserv, Inc. following a class action lawsuit alleging that the company overstated its growth by not disclosing issues with its Clover payment platform [1][3]. Group 1: Lawsuit Details - The class action lawsuit claims that Fiserv and certain executives failed to disclose that Clover's revenue growth was artificially boosted by forcing merchants to transition from the legacy Payeezy platform [3]. - Investors became aware of Fiserv's true financial situation after the company lowered its 2025 organic growth projections on July 23, 2025, leading to a significant decline in share price [4]. Group 2: Investor Information - Investors who purchased Fiserv securities between July 24, 2024, and July 22, 2025, have until September 22, 2025, to seek appointment as lead plaintiff representatives [2][5].
Global Blue Group Holding (GB) Earnings Call Presentation
2025-06-30 12:25
Company Overview - Global Blue is a leader in tax-free shopping, operating at the intersection of travel and luxury retail, with a simple revenue model based on a percentage of tax-free spending[12] - The company estimates its enterprise value to be approximately €1.8 billion, calculated from an equity value of ~€1.2 billion plus net debt and other debt-like items of ~€0.6 billion[12, 13] - Global Blue's Tax Free Shopping (TFS) Sales in Store (SiS) completed amounted to €20 billion in FY23/24[15] - The company has a 70% market share in Tax Free Shopping[12, 26] Financial Performance - The company achieved over €200 million in annualized Adjusted EBITDA[11, 36] - Global Blue has historically demonstrated strong cash conversion, with over 80% cash conversion rate[12] - In FY23/24, Global Blue experienced a 36% year-over-year increase in Group Revenue and a 91% year-over-year increase in Adjusted EBITDA[34, 35] - Q1 FY24/25 results show a 25% year-over-year revenue growth and a 55% year-over-year Adjusted EBITDA growth, with an Adjusted EBITDA margin of 37%[37] Growth and Future Targets - The company is targeting long-term revenue growth of 8% to 12%[49, 50] - Global Blue is aiming for a long-term capital structure with net debt to LTM EBITDA ratio of less than 25x[51, 52] - The company is guiding for more than €200 million in EBITDA for the current financial year[49, 50]
Affirm's Active Merchants Rise: A Strategic Advantage in BNPL Space?
ZACKS· 2025-06-12 16:51
Core Insights - Affirm Holdings, Inc. (AFRM) is focusing on growth and merchant expansion, particularly in the Buy Now Pay Later (BNPL) market, with significant merchant adoption on its platform [1] - The company has expanded into the U.K. market, marking a major step outside North America [1] Merchant Growth - Affirm reported over 254,000 active merchants in fiscal 2023, which increased by approximately 19.3% year over year in fiscal 2024, and reached around 358,000 active merchants by the end of the third quarter of fiscal 2025, reflecting a 23% year-over-year growth [2][11] Gross Merchandise Volume (GMV) - The increasing participation of merchants has led to more checkout opportunities, significantly boosting GMV, which surged 36% year over year to $8.6 billion in the fiscal third quarter of 2025. The company projects GMV to be between $35.7 billion and $36 billion for fiscal 2025 [3][11] Revenue and Partnerships - Merchant network revenues rose 34.3% year over year in the fiscal third quarter of 2025, supported by strategic partnerships and product enhancements. The company aims to enhance its product lineup with more flexible payment options and improved point-of-sale integrations [4][11] Competitive Landscape - Competitors in the payment solutions space include PayPal Holdings, Inc. (PYPL) and Sezzle Inc. (SEZL). PayPal reported 436 million active accounts and net revenues of $7.8 billion in the first quarter of 2025, while Sezzle's total revenues grew 123.3% year over year to $104.9 million in the same quarter [5][6] Stock Performance and Valuation - Over the past year, AFRM's shares have increased by 90%, outperforming the industry's growth of 37.4%. The company trades at a forward price-to-sales ratio of 5.25, below the industry average of 5.68 [9][10] Earnings Estimates - The Zacks Consensus Estimate for Affirm's 2025 earnings implies a growth of 100.6% from the previous year, with five upward estimate revisions in the past 30 days [13]
Visa vs. AmEx: Which Payment Stock Has the Edge Now for Future Gains?
ZACKS· 2025-05-21 13:36
Core Viewpoint - Visa Inc. and American Express Company are both leaders in the payment solutions industry, benefiting from the growth of digital payments and consumer spending, but their differing business models impact investor returns [1][2]. Group 1: American Express - American Express operates a premium, relationship-driven model that combines payment processing with direct lending, allowing it to capture more value per customer compared to Visa [3]. - In Q1 2025, American Express reported a 7% year-over-year revenue growth, with network volumes of $439.6 billion increasing by 5% and total interest income rising by 6% to $6.1 billion [4]. - The affluent user base of American Express continues to spend on travel, dining, and entertainment, supported by exclusive offers and loyalty programs [5]. - American Express maintains a robust balance sheet with cash and cash equivalents of $52.5 billion, and its provision for credit losses declined by 9% year-over-year to $1.2 billion in Q1 [6]. - The Zacks Consensus Estimate for American Express indicates year-over-year sales and EPS growth of 8.1% and 13.7%, respectively, for fiscal 2025 [11]. - American Express trades at a forward earnings multiple of 18.51, reflecting its double-digit growth potential [12]. - Over the past month, American Express shares have rallied over 17%, driven by structural growth factors [14]. Group 2: Visa - Visa operates an asset-light, transaction-based model, earning fees for processing payments, which is considered low-risk [7]. - In Q2 fiscal 2025, Visa reported a 9.3% increase in net revenues, with payments volume increasing by 8% and processed transactions growing by 9% to 60.7 billion [8]. - Visa's business model lacks direct consumer relationships, relying on banks and merchants, which limits its control over the end-user experience [9]. - Visa is investing in B2B payments, real-time transfers, and payment security, but faces regulatory scrutiny due to its size [10]. - The Zacks Consensus Estimate for Visa indicates year-over-year sales and EPS growth of 12.9% and 10.3%, respectively, for fiscal 2025 [11]. - Visa trades at a higher forward earnings multiple of 29.94, which reflects its consistent performance but offers less room for upside surprises [12]. - Over the past year, Visa shares have gained 10.7%, with growth appearing more incremental compared to American Express [14]. Group 3: Comparative Analysis - American Express shows greater upside potential due to its dual revenue streams and strong customer loyalty, particularly among younger demographics [17]. - Both companies currently hold a Zacks Rank of 3 (Hold), but American Express is viewed as having more attractive valuation and growth prospects in the current market environment [17].
Marqeta: A Risky Investment or a Future Leader in Payment Solutions?
The Motley Fool· 2025-05-09 23:00
Core Insights - The article discusses Marqeta (MQ) and highlights its potential as an investment opportunity within the payment processing industry [1] Group 1: Company Overview - Marqeta is positioned in the payment processing sector, offering innovative solutions that cater to modern financial needs [1] - The company has been recognized for its growth potential and market trends that could influence its performance [1] Group 2: Market Trends - The video accompanying the article provides insights into current market trends that may impact Marqeta's business [1] - Analysts emphasize the importance of understanding these trends for identifying potential investment opportunities [1]
Paysign(PAYS) - 2025 Q1 - Earnings Call Transcript
2025-05-08 22:02
Financial Data and Key Metrics Changes - Revenue grew 41% year over year to $18.6 million, up from $13.2 million in Q1 of last year [5] - Net income surged to $2.59 million, a 737% increase over Q1 2024 [5] - Adjusted EBITDA jumped 193% to $4.9 million, with gross margin expanding over 10 points to 62.9% [5][6] Business Line Data and Key Metrics Changes - Patient Affordability business revenues rose 261% year over year to $8.6 million, with claims processed growing by more than 160% [6] - Plasma donor compensation revenue decreased 9.2% to $9.4 million, with revenue per plasma center declining to $6,517 [10][14] Market Data and Key Metrics Changes - The Patient Affordability segment accounted for 46.3% of quarterly revenues, a significant increase from 18.1% in the same period last year [15] - The company ended the quarter with 484 plasma centers, adding four new centers during the period [10][14] Company Strategy and Development Direction - The acquisition of Gamma Innovation is expected to enhance the tech stack and offer a full front-end engagement platform integrated with core payment solutions [11][12] - The company aims to unlock additional revenue streams and expand its total addressable market beyond the plasma sector into broader pharmaceutical and healthcare sectors [12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth trajectory and commitment to delivering long-term value to shareholders [13] - The company expects patient affordability revenue to more than double again in 2025 based on current pipeline and results [8] Other Important Information - The company exited the quarter with $6.9 million in unrestricted cash and zero debt [17] - Full-year gross profit margins are expected to be between 62% to 64%, reflecting stable margins in the plasma business and increased contributions from the higher-margin pharma patient affordability business [18] Q&A Session Summary - No questions were raised during the Q&A session [21]